ATE378044T1 - Verwendung von rhein oder seinen derivaten als matrix metalloproteinase inhibitoren - Google Patents

Verwendung von rhein oder seinen derivaten als matrix metalloproteinase inhibitoren

Info

Publication number
ATE378044T1
ATE378044T1 AT01985586T AT01985586T ATE378044T1 AT E378044 T1 ATE378044 T1 AT E378044T1 AT 01985586 T AT01985586 T AT 01985586T AT 01985586 T AT01985586 T AT 01985586T AT E378044 T1 ATE378044 T1 AT E378044T1
Authority
AT
Austria
Prior art keywords
rhine
derivatives
matrix metalloproteinase
metalloproteinase inhibitors
present
Prior art date
Application number
AT01985586T
Other languages
English (en)
Inventor
Stephen Quirk
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Application granted granted Critical
Publication of ATE378044T1 publication Critical patent/ATE378044T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01985586T 2000-12-29 2001-12-21 Verwendung von rhein oder seinen derivaten als matrix metalloproteinase inhibitoren ATE378044T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/753,140 US6600057B2 (en) 2000-12-29 2000-12-29 Matrix metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
ATE378044T1 true ATE378044T1 (de) 2007-11-15

Family

ID=25029329

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01985586T ATE378044T1 (de) 2000-12-29 2001-12-21 Verwendung von rhein oder seinen derivaten als matrix metalloproteinase inhibitoren

Country Status (9)

Country Link
US (1) US6600057B2 (de)
EP (1) EP1381355B1 (de)
KR (1) KR100829330B1 (de)
AT (1) ATE378044T1 (de)
CA (1) CA2430672A1 (de)
DE (1) DE60131464T2 (de)
ES (1) ES2294040T3 (de)
MX (1) MXPA03005866A (de)
WO (1) WO2002053146A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050019743A1 (en) * 2001-05-03 2005-01-27 Center For Blood Research, Inc. Compounds and methods for improving platelet recovery and function
JP2005515191A (ja) * 2001-11-29 2005-05-26 グレイストーン メディカル グループ、インコーポレイテッド 創傷の治療及び使用する組成物
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
GB2398779A (en) * 2003-02-26 2004-09-01 Arakis Ltd 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as modulators of IL-10 production for treatment of autoimmune or inflammatory conditions
GB2398780A (en) * 2003-02-26 2004-09-01 Arakis Ltd 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as inhibitors of T-cell proliferation for treatment of autoimmune or inflammatory conditions
US20070160655A1 (en) * 2003-04-23 2007-07-12 Sefton Michael V Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases
US20040213758A1 (en) * 2003-04-23 2004-10-28 Rimon Therapeutics Ltd. Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases
US20110086070A1 (en) * 2008-03-24 2011-04-14 Munish Talwar Orally disintegrating compositions of rhein or diacerein
JP4560822B2 (ja) * 2008-08-01 2010-10-13 Ａｘｉｓ株式会社 変形性関節症治療剤又は予防剤
CN102060809B (zh) * 2009-05-01 2015-05-20 常州高新技术产业开发区三维工业技术研究所有限公司 一种大黄酸衍生物及其制备和用途
US20170274013A1 (en) 2013-09-16 2017-09-28 Patrick T. Prendergast Wound fluid elevated protease enzyme inhibition through camelid blood products
CN103709052B (zh) * 2014-01-12 2016-01-27 何黎琴 一种大黄酸胺基醇酯类化合物、其制备方法及医药用途
CA2976096C (en) 2014-02-20 2023-03-14 University Of Notre Dame Du Lac Substituted 2-[(4-phenoxyphenyl)sulfonylmethyl]thiirane as selective matrix metalloproteinase inhibitors
WO2016044844A1 (en) 2014-09-19 2016-03-24 University Of Notre Dame Du Lac Acceleration of diabetic wound healing
CN108530343B (zh) * 2018-04-08 2021-07-27 南京师范大学 一种大黄酸特定基团修饰的有机化合物、其芳基金属配合物、及其制备方法和应用
CN108821999A (zh) * 2018-04-26 2018-11-16 南昌大学 一种氨基酸异羟肟酸类氨肽酶n抑制剂及制备方法
CN112920141B (zh) * 2019-12-05 2023-03-17 中检科医药科技(北京)集团有限公司 一类大黄酸衍生物及其抗病毒用途
TW202404945A (zh) * 2022-04-12 2024-02-01 印度商齊杜斯生命科學公司 治療細胞激素相關疾病之新穎化合物

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
CS249311B1 (en) 1983-09-29 1987-03-12 Jaroslava Turkova Proteolytic wound dressing
GB2150833B (en) 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
US4999285A (en) 1984-11-15 1991-03-12 Syntex (U.S.A.) Inc. Chromatographic cassette
US4868108A (en) 1985-12-12 1989-09-19 Hygeia Sciences, Incorporated Multiple-antibody detection of antigen
DE3606265A1 (de) 1986-02-27 1987-09-03 Roehm Pharma Gmbh Wundauflage auf polysaccharidbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme und mit hoher saugfaehigkeit
US5112608A (en) 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing
US5196196A (en) 1986-06-03 1993-03-23 Incyte Pharmaceuticals, Inc. Use of protease nexin-I in wound dressings
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4943522A (en) 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
CA1313616C (en) 1987-06-01 1993-02-16 Robert B. Sargeant Lateral flow, non-bibulous membrane protocols
ATE86746T1 (de) 1987-09-11 1993-03-15 Abbott Lab Geraet fuer die laterale immunochromatographische bestimmung.
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DK158336C (da) 1987-09-22 1990-10-01 Coloplast As Forbindsmateriale til behandling af saar samt smaalegemer til brug ved fremstilling deraf
US4876332A (en) 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
US5275785A (en) 1987-10-30 1994-01-04 Unilever Patent Holdings B.V. Test device for detecting an analyte in a liquid sample
US5670381A (en) 1988-01-29 1997-09-23 Abbott Laboratories Devices for performing ion-capture binding assays
US5270447A (en) 1988-05-20 1993-12-14 The United States Of America As Represented By The Department Of Health & Human Services Metalloproteinase peptides: role in diagnosis and therapy
US5280106A (en) 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US4883760A (en) 1988-06-20 1989-11-28 Adi Diagnostics Inc. Device for performing enzyme immunoassays
US5037735A (en) 1988-06-24 1991-08-06 Microgenics Corporation Visual discrimination qualitative enzyme complementation assay
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5188938A (en) 1988-12-29 1993-02-23 Microgenics Corporation Enzyme quantitation wicking assay
EP0464147B1 (de) 1989-03-21 2002-06-26 THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE Matrizenmetalloproteinase-inhibitor-peptide
US5698671A (en) 1989-03-21 1997-12-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metalloproteinase peptides
JPH02304365A (ja) 1989-05-18 1990-12-18 Shionogi & Co Ltd エラスターゼ１の測定方法
NO177716C (no) 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
CZ277766B6 (en) 1990-01-04 1993-04-14 Vnii Textilno Biologically active material and process for preparing thereof
JPH0734014B2 (ja) 1990-01-26 1995-04-12 アメリカ合衆国 コラーゲナーゼを定量的に測定するための方法
US5141850A (en) 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
US5270168A (en) 1990-02-21 1993-12-14 Board Of Regents, The University Of Texas System Method for diagnosing non-healing ulcers
US5169754A (en) 1990-10-31 1992-12-08 Coulter Corporation Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
GB2250993B (en) 1990-11-21 1995-02-15 Inst Nat Sante Rech Med Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer
US5484726A (en) 1990-11-21 1996-01-16 Bristol-Myers Squibb Company Antibodies specific for human stromelysin-3 and a method for detection of stromelysin-3
WO1992012428A1 (en) 1991-01-11 1992-07-23 Quidel Corporation A one-step lateral flow nonbibulous assay
JPH085920B2 (ja) 1991-01-21 1996-01-24 富士薬品工業株式会社 抗ヒトストロムライシンモノクローナル抗体及び酵素免疫測定法
JP3118015B2 (ja) 1991-05-17 2000-12-18 アークレイ株式会社 バイオセンサーおよびそれを用いた分離定量方法
FR2678513B1 (fr) 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
JP3135959B2 (ja) 1991-12-12 2001-02-19 アークレイ株式会社 バイオセンサーおよびそれを用いた分離定量方法
CZ26693A3 (en) * 1992-02-28 1993-12-15 Lilly Industries Ltd Pharmaceutical compositions
US5541069A (en) 1992-02-28 1996-07-30 Quidel Corporation Assay having improved dose response curve
DE69329377T2 (de) 1992-03-10 2001-04-05 Quidel Corp., San Diego Trennmittel für rote blutkörperchen bei untersuchungen mit spezifischer bindung
US5324634A (en) 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US5516891A (en) 1992-06-16 1996-05-14 Kinerton, Ltd. Liquid phase synthesis of peptides and peptide derivatives
US5354692A (en) 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
IT1270951B (it) 1993-06-07 1997-05-26 Boehringer Mannheim Italia Metodo e dispositivo per il rilevamento simultano di neisseria gonorrhoeae, chlamydia trachomatis e mycoplasma
US5415994A (en) 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
GB9405076D0 (en) 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
US5641636A (en) 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
GB9414303D0 (en) 1994-07-15 1994-09-07 C V Lab Ltd Alginate fibres, method of preparation and use
AU3276895A (en) 1994-07-28 1996-02-22 Pall Corporation Fibrous web and process of preparing same
FI98961C (fi) 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5605809A (en) 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
US5916521A (en) 1995-01-04 1999-06-29 Spectral Diagnostics, Inc. Lateral flow filter devices for separation of body fluids from particulate materials
US5569608A (en) 1995-01-30 1996-10-29 Bayer Corporation Quantitative detection of analytes on immunochromatographic strips
US5652265A (en) * 1995-03-29 1997-07-29 Wisconsin Alumni Research Foundation Production of rhein and rhein derivatives
US5712172A (en) 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US6020181A (en) 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US5830468A (en) 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
US5770691A (en) 1995-06-05 1998-06-23 Regents Of The University Of Minnesota Discriminatory substrates for MMP hydrolysis
IT1276781B1 (it) * 1995-06-23 1997-11-03 Gentili Ist Spa Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie
US5935796A (en) 1995-06-30 1999-08-10 The University Of Melbourne Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
WO1997004080A1 (en) 1995-07-14 1997-02-06 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel protein and monoclonal antibody specific thereto
US5952236A (en) 1995-10-26 1999-09-14 Thompson; Richard B. Enzyme-based fluorescence biosensor for chemical analysis
WO1997025437A1 (en) 1996-01-04 1997-07-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for assaying proteolytic enzymes using fluorescence-quenched substrates
US5741659A (en) 1996-01-04 1998-04-21 The United States Of America As Represented By The Secretary Of The Navy Rapid microbial protease assay
ATE405672T1 (de) 1996-02-29 2008-09-15 Fujifilm Corp Verfahren zur analyse von proteasen und dünner membran zur verwendung dieses verfahrens
US5876944A (en) 1996-06-10 1999-03-02 Bayer Corporation Method for amplification of the response signal in a sandwich immunoassay
US6022948A (en) 1996-09-17 2000-02-08 Washington University Method of cell surface activation and inhibition
US5798273A (en) 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
ATE286252T1 (de) 1996-10-25 2005-01-15 Idexx Lab Inc Immunoassay-vorrichtung mit teilbarem gehäuse
US5710005A (en) 1996-10-29 1998-01-20 Biocode, Inc. Analyte detection with a gradient lateral flow device
US6194221B1 (en) 1996-11-19 2001-02-27 Wyntek Diagnostics, Inc. Hybrid one-step immunochromatographic device and method of use
US6025150A (en) 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
US5922550A (en) 1996-12-18 1999-07-13 Kimberly-Clark Worldwide, Inc. Biosensing devices which produce diffraction images
GB2320431B (en) 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
DE19701141C1 (de) 1997-01-16 1998-04-09 Hoechst Ag Genkonstrukte für durch Proteasen aktivierbare Wirksubstanzen
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
GB2322192B (en) 1997-02-14 2001-01-31 Unilever Plc Assay devices
US6037137A (en) 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
US6294344B1 (en) 1997-03-19 2001-09-25 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US6180288B1 (en) 1997-03-21 2001-01-30 Kimberly-Clark Worldwide, Inc. Gel sensors and method of use thereof
US6258548B1 (en) 1997-06-05 2001-07-10 A-Fem Medical Corporation Single or multiple analyte semi-quantitative/quantitative rapid diagnostic lateral flow test system for large molecules
US5895765A (en) 1997-06-30 1999-04-20 Bayer Corporation Method for the detection of an analyte by immunochromatography
US5985675A (en) 1997-12-31 1999-11-16 Charm Sciences, Inc. Test device for detection of an analyte
US6043087A (en) 1997-07-25 2000-03-28 The New York Blood Center Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen)
US6060256A (en) 1997-12-16 2000-05-09 Kimberly-Clark Worldwide, Inc. Optical diffraction biosensor
US6183972B1 (en) 1998-07-27 2001-02-06 Bayer Corporation Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect
US6143506A (en) 1998-08-13 2000-11-07 The Research Foundation Of State Of Ny Diagnostic method for detection of periodontitis or peri-implantitis
US6136610A (en) 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
US6203757B1 (en) 1998-12-02 2001-03-20 Bionike, Inc. Fluid sample distriution system for test device
US6221579B1 (en) 1998-12-11 2001-04-24 Kimberly-Clark Worldwide, Inc. Patterned binding of functionalized microspheres for optical diffraction-based biosensors
US6297020B1 (en) 1999-03-01 2001-10-02 Bayer Corporation Device for carrying out lateral-flow assays involving more than one analyte

Also Published As

Publication number Publication date
ES2294040T3 (es) 2008-04-01
MXPA03005866A (es) 2005-02-14
US6600057B2 (en) 2003-07-29
KR20030064886A (ko) 2003-08-02
WO2002053146A2 (en) 2002-07-11
DE60131464T2 (de) 2008-02-28
KR100829330B1 (ko) 2008-05-13
CA2430672A1 (en) 2002-07-11
EP1381355B1 (de) 2007-11-14
DE60131464D1 (de) 2007-12-27
US20020086877A1 (en) 2002-07-04
WO2002053146A3 (en) 2003-10-30
EP1381355A2 (de) 2004-01-21

Similar Documents

Publication Publication Date Title
ATE378044T1 (de) Verwendung von rhein oder seinen derivaten als matrix metalloproteinase inhibitoren
ATE182137T1 (de) Peptidylderivate als inhibitoren von metalloproteinase
ATE308364T1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE459359T1 (de) Verwendung von kondensierten heterozyklischen verbindungen als scce-hemmern zur behandlung von hautzuständen
PT927161E (pt) Aminas ciclicas substituidas inibidoras de metaloproteases
BR0011130A (pt) Inibidores de metaloproteases
DK1030836T3 (da) Hydroxam- og carboxylsyrederivater der har MMP- og TNF-inhiberende aktivitet
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69940480D1 (de) Carbocyclische kaliumkanalhemmer
ATE368034T1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
ATE365551T1 (de) Fusionierte heteroaryl-derivative zur verwendung als p38 kinase inhibitoren zur behandlung von u.a rheumatischer arthritis
NO20004093L (no) e-inhibitorer
ATE257013T1 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
ATE251141T1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
ATE450515T1 (de) Anilinopyrimidinderivate als ikk?inhibitoren, und hiermit in zusammenhang stehende zusammensetzungen und verfahren
EA200200120A1 (ru) Соединения индазола, фармацевтические препараты для ингибирования протеинкиназ и способы их применения
YU40999A (sh) N-hidroksi-2-(alkil,aril ili heteroaril sulfanil,sulfinil ili sulfonil)-3-supstituisani alkil,aril ili heteroarilamidi, kao inhibitori za matrične metaloproteinaze
ATE530179T1 (de) Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen
DE69819878D1 (de) Divalente sulfonyl-aryl-oder heteroaryl hydroxamsäureverbindungen
DE60309739D1 (de) Pyridinderivate als modulatoren des cb2-rezeptors
MXPA04010555A (es) Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
NO20000784L (no) Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt
DE69912432D1 (de) Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide
DK1071704T3 (da) Nye matrix metalloproteinasehæmmere og nedregulatorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties